SUGAMMADEX SODIUM
- Product NDC
- 42023-830
- Requested package NDC
- 42023-830-10
- 11-digit product format
- 420230830
- Labeler code
- 42023
- Product ID
- 42023-830_57d27f48-e8f1-531b-e063-6294a90ac2cb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- SUGAMMADEX SODIUM
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Par Health USA, LLC
- Application
- ANDA218814
- Marketing category
- ANDA
- Marketing start
- 2026-07-28
- Substance
- SUGAMMADEX SODIUM
- Active strength
- 200 mg/2mL
- Pharmacologic classes
- gamma-Cyclodextrins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218814-001 | SUGAMMADEX SODIUM | SUGAMMADEX SODIUM | EQ 200MG BASE/2ML (EQ 100MG BASE/ML) | SOLUTION / INTRAVENOUS | AP | 2026-07-28 | |
| A218814-002 | SUGAMMADEX SODIUM | SUGAMMADEX SODIUM | EQ 500MG BASE/5ML (EQ 100MG BASE/ML) | SOLUTION / INTRAVENOUS | AP | 2026-07-28 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A218814-001 | AP |
| A218814-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218814-001 | SUGAMMADEX SODIUM | EQ 200MG BASE/2ML (EQ 100MG BASE/ML) | SOLUTION / INTRAVENOUS | AP | 2026-07-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A218814-002 | SUGAMMADEX SODIUM | EQ 500MG BASE/5ML (EQ 100MG BASE/ML) | SOLUTION / INTRAVENOUS | AP | 2026-07-28 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A218814-001 | SUGAMMADEX SODIUM | EQ 200MG BASE/2ML (EQ 100MG BASE/ML) | SOLUTION / INTRAVENOUS | AP | 2026-07-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A218814-002 | SUGAMMADEX SODIUM | EQ 500MG BASE/5ML (EQ 100MG BASE/ML) | SOLUTION / INTRAVENOUS | AP | 2026-07-28 | caaa826d4ba7… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218814-001 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A218814-002 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A218814-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A218814-002 | AP | 1 | caaa826d4ba7… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- SUGAMMADEX SODIUM
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SUGAMMADEX SODIUM | 200 mg/2mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| ERJ6X2MXV7 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 579a2a1f-4d0c-4851-e063-6294a90a2be6 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SUGAMMADEX SODIUM | SUGAMMADEX SODIUM | Par Health USA, LLC | 579a2a1f-4d0c-4851-e063-6294a90a2be6 | 2026-07-28 | Warnings, Adverse reactions | 218814 ANDA218814 42023-830-10 42023-830 42023083010 |
| SUGAMMADEX SODIUM | SUGAMMADEX SODIUM | STERISCIENCE SPECIALTIES PRIVATE LIMITED | 0379799d-b678-4eb1-8f15-7dd183ee2a6e | 2026-07-28 | Warnings, Adverse reactions | 218814 ANDA218814 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 42023-830-10 | 42023083010 | 10 SYRINGE in 1 CARTON (42023-830-10) / 2 mL in 1 SYRINGE | 10 syringe | 2026-07-28 | Yes | No | Current |